|
Volumn 7, Issue 4, 2000, Pages 287-291
|
Treatment of chronic hepatitis C genotype IV with interferon-ribavirin combination in Saudi Arabia: A multicentre study
a,b,c,d,e,f a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e a,b,c,d,e |
Author keywords
Genotype 4; Hepatitis C; Interferon ; Ribavirin
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
HEMOGLOBIN;
INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RIBAVIRIN;
VIRUS RNA;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANEMIA;
ANXIETY NEUROSIS;
ARTICLE;
ASCITES;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
HEMOGLOBIN DETERMINATION;
HEPATITIS C;
HEPATITIS C VIRUS;
HISTOPATHOLOGY;
HUMAN;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
SAUDI ARABIA;
STAGING;
TREATMENT OUTCOME;
VIRUS LOAD;
VIRUS STRAIN;
ADULT;
ANTIVIRAL AGENTS;
DRUG THERAPY, COMBINATION;
FEMALE;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
MALE;
MIDDLE AGED;
RIBAVIRIN;
SAUDI ARABIA;
|
EID: 0033925286
PISSN: 13520504
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2893.2000.00213.x Document Type: Article |
Times cited : (31)
|
References (16)
|